We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$836M
AUM Growth
+$4.91M
Cap. Flow
-$16.6M
Cap. Flow %
-1.98%
Top 10 Hldgs %
38.74%
Holding
112
New
6
Increased
28
Reduced
28
Closed
20

Top Buys

Rank Stock Value
1
TNDM icon
Tandem Diabetes Care
TNDM
+$11.9M
2
KYNB
Kyntra Bio
KYNB
+$9.69M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$9.43M
4
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$6.67M
5
IMMU
Immunomedics Inc
IMMU
+$6.3M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$17M
2
UNH icon
UnitedHealth
UNH
+$8.53M
3
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
+$5.93M
4
ADMS
Adamas Pharmaceuticals
ADMS
+$5.75M
5
PODD icon
Insulet
PODD
+$5.61M

Sector Composition

Rank Sector Weight
1 Healthcare 85.37%
2 Industrials 2.83%
3 Technology 2.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GBT
26
DELISTED
Global Blood Therapeutics, Inc.
GBT
$11.9M 1.42%
226,241
-47,100
-17% -$2.71M
LLY icon
27
Eli Lilly
LLY
$1.07T
$11.8M 1.41%
106,665
-4,800
-4% -$565K
ATRC icon
28
AtriCure
ATRC
$1.85B
$11.6M 1.38%
387,224
-5,899
-2% -$172K
ASMB icon
29
Assembly Biosciences
ASMB
$522M
$11.4M 1.37%
70,641
+10,991
+18% +$2.09M
XLRN
30
DELISTED
Acceleron Pharma
XLRN
$11.1M 1.32%
269,396
– –
EVH icon
31
Evolent Health
EVH
$454M
$10.8M 1.29%
1,358,352
+153,950
+13% +$1.82M
STML
32
DELISTED
Stemline Therapeutics, Inc.
STML
$10.2M 1.22%
666,158
+70,100
+12% +$1.01M
HMSY
33
DELISTED
HMS Holdings Corp.
HMSY
$10.1M 1.21%
311,278
+56,721
+22% +$1.73M
BSX icon
34
Boston Scientific
BSX
$68.6B
$9.74M 1.16%
226,576
-15,300
-6% -$588K
BMY icon
35
Bristol-Myers Squibb
BMY
$129B
$9.74M 1.16%
214,697
-4,000
-2% -$186K
ALXN
36
DELISTED
Alexion Pharmaceuticals
ALXN
$9.59M 1.15%
+73,199
New +$9.43M
VRAY
37
DELISTED
ViewRay, Inc.
VRAY
$9.44M 1.13%
1,071,265
-51,999
-5% -$422K
ALBO
38
DELISTED
Albireo Pharma Inc
ALBO
$7.83M 0.94%
242,978
– –
MDT icon
39
Medtronic
MDT
$109B
$7.49M 0.9%
76,851
-27,100
-26% -$2.47M
CI icon
40
Cigna
CI
$76.9B
$7.45M 0.89%
47,313
+6,504
+16% +$1.02M
INSP icon
41
Inspire Medical Systems
INSP
$1.47B
$7.33M 0.88%
120,900
+35,000
+41% +$1.89M
OBSV
42
DELISTED
ObsEva SA Ordinary Shares
OBSV
$7.27M 0.87%
643,151
+14,459
+2% +$182K
ABT icon
43
Abbott
ABT
$184B
$7M 0.84%
83,198
-14,400
-15% -$1.13M
FTSV
44
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$6.96M 0.83%
656,651
+190,149
+41% +$2.79M
VRTX icon
45
Vertex Pharmaceuticals
VRTX
$123B
$6.93M 0.83%
37,771
+17,500
+86% +$3.06M
IRTC icon
46
iRhythm Holdings
IRTC
$3.71B
$6.85M 0.82%
86,600
+4,000
+5% +$291K
CBIO
47
Crescent Biopharma
CBIO
$642M
$6.59M 0.79%
5,528
+48
+0.9% +$57.4K
CHNG
48
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$6.58M 0.79%
+450,550
New +$6.67M
MGTX icon
49
MeiraGTx Holdings
MGTX
$1.14B
$6.07M 0.73%
225,906
-94,990
-30% -$1.96M
EVLO
50
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$6.01M 0.72%
33,469
+915
+3% +$148K
1
2
3 4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Sectoral Asset Management held 112 positions worth $836M, up 0.59% from $831M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Sectoral Asset Management's Q2 2019 filing shows 6 new, 28 increased, 28 reduced and 20 closed positions. Its largest new stake was Alexion Pharmaceuticals: 73,199 shares worth $9.59M. The largest sale was Celgene Corp, an estimated $17M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 85% a quarter earlier, followed by Industrials and Technology.

  • Sectoral Asset Management's largest Q2 2019 buy was Alexion Pharmaceuticals: 73,199 shares worth $9.59M.
  • Sectoral Asset Management added most to Tandem Diabetes Care in Q2 2019, an estimated $11.9M increase.
  • Sectoral Asset Management's biggest Q2 2019 reduction was Insulet, cutting an estimated $5.61M.
  • Sectoral Asset Management fully exited Celgene Corp in Q2 2019, selling an estimated $17M.
  • Sectoral Asset Management's ten largest holdings make up 39% of its $836M portfolio in Q2 2019.
  • Sectoral Asset Management opened 6 new positions and closed 20 in Q2 2019.
  • Sectoral Asset Management's portfolio value rose 0.59% quarter-over-quarter to $836M.

Based on Sectoral Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.